View All Newsletters

Late-stage venture-backed software companies have been impacted significantly by the current macroeconomic uncertainties. The drop off in IPOs and acquisition activity has delayed planned liquidity events, and for those requiring capital to bridge th…

In the wake of the supply chain vulnerabilities that were exacerbated during the COVID-19 pandemic and considering disruptions that continue to date, pharmaceutical companies are reassessing their global operating model.

FASB recently issued ASU No. 2022-03, which amends the fair value guidance in U.S. GAAP to increase comparability of financial information.

Privileged asset management, or PAM, is a protocol that consists of applying disciplined cybersecurity strategies and technologies to exert control over “privileged” or elevated access and permissions for users, accounts, processes, applications, and…

Many mutual funds are now converting into ETFs, a trend the industry has seen since last year. This article offers insight into the conversion process, and the issues to consider along the way.

Businesses are expanding their payment options to include cryptocurrency -- yet the complexity and regulatory uncertainty surrounding crypto presents a difficult value proposition. This article highlights potential benefits and risks of accepting cry…

ESG has become a competitive advantage for life sciences companies that are rethinking what it means to attain security and resiliency. ESG, among other things, can be used to measure how vulnerable a company is to an external threat.

A conversation with Monica Blocker of Houlihan Capital who shares her outlook on the possible amendments to the Investment Advisers Act of 1940 and the effect on valuations.

The consensus is that emerging VC funds will find it harder to raise capital this year. This article examines ways for managers to build a robust business that helps them stand out in a more competitive market.